Compare IRMD & BTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRMD | BTZ |
|---|---|---|
| Founded | 1992 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 998.6M |
| IPO Year | 2014 | N/A |
| Metric | IRMD | BTZ |
|---|---|---|
| Price | $82.62 | $9.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $116.00 | N/A |
| AVG Volume (30 Days) | 82.5K | ★ 329.7K |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | 0.95% | ★ 9.40% |
| EPS Growth | ★ 16.67 | N/A |
| EPS | 0.86 | ★ 1.41 |
| Revenue | ★ $83,814,000.00 | N/A |
| Revenue This Year | $12.38 | N/A |
| Revenue Next Year | $11.31 | N/A |
| P/E Ratio | $96.21 | ★ $6.83 |
| Revenue Growth | ★ 14.43 | N/A |
| 52 Week Low | $67.84 | $9.54 |
| 52 Week High | $107.90 | $11.18 |
| Indicator | IRMD | BTZ |
|---|---|---|
| Relative Strength Index (RSI) | 33.55 | 24.16 |
| Support Level | $82.25 | N/A |
| Resistance Level | $88.93 | $10.22 |
| Average True Range (ATR) | 2.01 | 0.09 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 19.55 | 4.10 |
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
Blackrock Credit Allocation Income Trust is a diversified, closed-end Trust engaged in providing investment advisory and risk management solutions. Its investment objective is to seek current income, current gains, and capital appreciation. The company invests under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment-grade corporate bonds, high-yields, bank loans, preferred securities or convertible bonds, or derivatives with economic characteristics similar to these credit-related securities.